Skip to content

Clinical trials

Phase 2 Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 2 Clear all

223 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
20026
20036
20046
200510
200611
20079
20089
200916
20108
201112
20127
20136
20142
20156
20164
20176
20183
20198
20206
20219
20229
20237
202411
20258
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed109
Unknown status35
Terminated30
Recruiting19
Active, not recruiting11
Not yet recruiting10
Withdrawn9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
Memorial Sloan Kettering Cancer Center8
M.D. Anderson Cancer Center5
Jennerex Biotherapeutics4
UNC Lineberger Comprehensive Cancer Center4
Alliance for Clinical Trials in Oncology3
Bayer3
Daiichi Sankyo3
Eli Lilly and Company3
Hoffmann-La Roche3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms223
Carcinoma, Hepatocellular131
Colorectal Neoplasms18
Neoplasm Metastasis18
Bile Duct Neoplasms15
Neoplasms14
Pancreatic Neoplasms14
Cholangiocarcinoma12
Gallbladder Neoplasms12
Liver Diseases10

Trials

Showing 51 to 75 of 223. Each trial links to its page on Pharma Observatory.

123 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.